See All Slides -

Slides

Presentation TCT 2016

Controversy 1. Is Cerebral Embolic Protection Needed for TAVR? The Evidence: Observations From DEFLECT 3, CLEAN-TAVI, and the SENTINEL Clinical Trials

Presenter: Raj Makkar, Lars Sondergaard, Samir R. Kapadia

October 31, 2016

Presentation TCT 2016

Trial #1 - The Essentials of ... ABSORB III Everolimus-Eluting Bioresorbable Vascular Scaffolds vs Everolimus-Eluting Metallic Stents in Coronary Artery Disease

Presenter: Sunil V. Rao, Harvey D. White, Stephen G. Ellis

October 31, 2016

Presentation TCT 2016

Next Generation MitraClip: Whats Better and Whats Not

Presenter: Ted Feldman, Scott Lim, Ralph Stephan von Bardeleben

October 31, 2016

Presentation TCT 2016

Introductory Lecture: Defining CHIP/Complex PCI in 2016 - Where We Are and Where We Need to Go

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses

October 31, 2016

Presentation TCT 2016

Left Main PCI vs CABG From the Asan Medical Center: Insights Into Patient Selection and Technique to Optimize Outcomes

Presenter: Seung-Jung Park, Leif Thuesen

October 31, 2016

Presentation TCT 2016

Implications of Bioresorbable Polymer/Metal Type, Processing, Thickness, Configuration, and Other Variables on Mechanical Properties, Vascular Compatibility, and Healing I: Pathologic Perspectives

Presenter: Elazer R. Edelman, Juan F. Granada, Renu Virmani

October 31, 2016

Presentation TCT 2016

Obstacles for Clinical Research: The BAMI Experience

Presenter: Emerson C. Perin, Ricardo Sanz-Ruiz

October 31, 2016

Presentation TCT 2016

Why I Became a CTO Operator and What It Means to Me

Presenter: James C. Spratt, Simon J. Walsh, Nicholas J. Lembo

October 31, 2016

Presentation TCT 2016

Primary PCI in Patients With Multivessel Disease: Overview of Randomized Trials and Unanswered Questions

Presenter: Ran Kornowski, Michel R. Le May, Kevin Bainey

October 31, 2016

Presentation TCT 2016

The Worldwide Epidemic of Peripheral Artery Disease, and Medical Interventions Which Really Work

Presenter: Tony Das, Koen Deloose, Ido Weinberg

October 31, 2016

Advertisement

Slides

Controversy 1. Is Cerebral Embolic Protection Needed for TAVR? The Evidence: Observations From DEFLECT 3, CLEAN-TAVI, and the SENTINEL Clinical Trials

Trial #1 - The Essentials of ... ABSORB III Everolimus-Eluting Bioresorbable Vascular Scaffolds vs Everolimus-Eluting Metallic Stents in Coronary Artery Disease

Next Generation MitraClip: Whats Better and Whats Not

Introductory Lecture: Defining CHIP/Complex PCI in 2016 - Where We Are and Where We Need to Go

Left Main PCI vs CABG From the Asan Medical Center: Insights Into Patient Selection and Technique to Optimize Outcomes

Implications of Bioresorbable Polymer/Metal Type, Processing, Thickness, Configuration, and Other Variables on Mechanical Properties, Vascular Compatibility, and Healing I: Pathologic Perspectives

Obstacles for Clinical Research: The BAMI Experience

Why I Became a CTO Operator and What It Means to Me

Primary PCI in Patients With Multivessel Disease: Overview of Randomized Trials and Unanswered Questions

The Worldwide Epidemic of Peripheral Artery Disease, and Medical Interventions Which Really Work

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content